A citation-based method for searching scientific literature


List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Consumers' views of pharmacogenetics--A qualitative study.
Catherine A Haddy, Helena M Ward, Manya T Angley, Ross A McKinnon. Res Social Adm Pharm 2010
34
100

Unsolicited information letters to increase awareness of Lynch syndrome and familial colorectal cancer: reactions and attitudes.
Helle Vendel Petersen, Birgitte Lidegaard Frederiksen, Charlotte Kvist Lautrup, Lars Joachim Lindberg, Steen Ladelund, Mef Nilbert. Fam Cancer 2019
9
100


Community pharmacists' attitudes towards clinical utility and ethical implications of pharmacogenetic testing.
Sony Tuteja, Kevin Haynes, Cara Zayac, Jon E Sprague, Barbara Bernhardt, Reed Pyeritz. Per Med 2013
41
100

Stakeholder views on returning research results.
Susanne B Haga, Jennifer Q Zhao. Adv Genet 2013
12
100

Perplexed by PGx? Exploring the impact of pharmacogenomic results on medical management, disclosures and patient behavior.
Larissa Waldman, Cheryl Shuman, Iris Cohn, Amy Kaiser, David Chitayat, Syed Wasim, Allison Hazell. Pharmacogenomics 2019
4
100


Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Dihydropyrimidine Dehydrogenase Genotype and Fluoropyrimidine Dosing: 2017 Update.
Ursula Amstutz, Linda M Henricks, Steven M Offer, Julia Barbarino, Jan H M Schellens, Jesse J Swen, Teri E Klein, Howard L McLeod, Kelly E Caudle, Robert B Diasio,[...]. Clin Pharmacol Ther 2018
183
100

Was it worth it? Patients' perspectives on the perceived value of genomic-based individualized medicine.
Colin Me Halverson, Kristin E Clift, Jennifer B McCormick. J Community Genet 2016
25
100

Survey of US public attitudes toward pharmacogenetic testing.
S B Haga, J M O'Daniel, G M Tindall, I R Lipkus, R Agans. Pharmacogenomics J 2012
100
100

Assessing Genetic Literacy Awareness and Knowledge Gaps in the US Population: Results from the Health Information National Trends Survey.
Melinda Krakow, Chelsea L Ratcliff, Bradford W Hesse, Alexandra J Greenberg-Worisek. Public Health Genomics 2017
29
100

Direct contact in inviting high-risk members of hereditary colon cancer families to genetic counselling and DNA testing.
K Aktan-Collan, A Haukkala, K Pylvänäinen, H J Järvinen, L A Aaltonen, P Peltomäki, E Rantanen, H Kääriäinen, J-P Mecklin. J Med Genet 2007
51
100

What Results Should Be Returned from Opportunistic Screening in Translational Research?
Colin Me Halverson, Sarah H Jones, Laurie Novak, Christopher Simpson, Digna R Velez Edwards, Sifang Kathy Zhao, Ellen W Clayton. J Pers Med 2020
4
100

Preliminary report of the relationship between experience of death of a relative, illness perception, and psychological outcome among BRCA carriers.
Dikla Samama, Ilanit Hasson-Ohayon, Shlomit Perry, Ofir Morag, Gil Goldzweig. Psychol Health Med 2014
5
100




Assessment of patient perceptions of genomic testing to inform pharmacogenomic implementation.
Yee Ming Lee, Ryan P McKillip, Brittany A Borden, Catherine E Klammer, Mark J Ratain, Peter H O'Donnell. Pharmacogenet Genomics 2017
22
100


Counselees' Perspectives of Genomic Counseling Following Online Receipt of Multiple Actionable Complex Disease and Pharmacogenomic Results: a Qualitative Research Study.
Kevin Sweet, Shelly Hovick, Amy C Sturm, Tara Schmidlen, Erynn Gordon, Barbara Bernhardt, Lisa Wawak, Karen Wernke, Joseph McElroy, Laura Scheinfeldt,[...]. J Genet Couns 2017
11
100

"Getting off the Bus Closer to Your Destination": Patients' Views about Pharmacogenetic Testing.
Susan Brown Trinidad, Tara B Coffin, Stephanie M Fullerton, James Ralston, Gail P Jarvik, Eric B Larson. Perm J 2015
9
100

The Single Item Literacy Screener: evaluation of a brief instrument to identify limited reading ability.
Nancy S Morris, Charles D MacLean, Lisa D Chew, Benjamin Littenberg. BMC Fam Pract 2006
383
100

Collaborative Counseling Considerations for Pharmacogenomic Tests.
Heather A Zierhut, Colleen A Campbell, Allison G Mitchell, Amy A Lemke, Rachel Mills, Jeffrey R Bishop. Pharmacotherapy 2017
18
100

Participants' recall and understanding of genomic research and large-scale data sharing.
Jill Oliver Robinson, Melody J Slashinski, Tao Wang, Susan G Hilsenbeck, Amy L McGuire. J Empir Res Hum Res Ethics 2013
31
100

Communicating genetic and genomic information: health literacy and numeracy considerations.
D H Lea, K A Kaphingst, D Bowen, I Lipkus, D W Hadley. Public Health Genomics 2011
142
100


Renal function, body surface area, and age are associated with risk of early-onset fluoropyrimidine-associated toxicity in patients treated with capecitabine-based anticancer regimens in daily clinical care.
Didier Meulendijks, J G Coen van Hasselt, Alwin D R Huitema, Harm van Tinteren, Maarten J Deenen, Jos H Beijnen, Annemieke Cats, Jan H M Schellens. Eur J Cancer 2016
24
100

The return of unexpected research results in a biobank study and referral to health care for heritable long QT syndrome.
A Haukkala, E Kujala, P Alha, V Salomaa, S Koskinen, H Swan, H Kääriäinen. Public Health Genomics 2013
24
100

An update to returning genetic research results to individuals: perspectives of the industry pharmacogenomics working group.
Sandra K Prucka, Lester J Arnold, John E Brandt, Sandra Gilardi, Lea C Harty, Feng Hong, Joanne Malia, David J Pulford. Bioethics 2015
8
100


Feedback of individual genetic results to research participants: in favor of a qualified disclosure policy.
Annelien L Bredenoord, N Charlotte Onland-Moret, Johannes J M Van Delden. Hum Mutat 2011
87
100


Qualitative data analysis: the framework approach.
Joanna Smith, Jill Firth. Nurse Res 2011
406
100

[Dihydropyrimidine déhydrogenase (DPD) deficiency screening and securing of fluoropyrimidine-based chemotherapies: Update and recommendations of the French GPCO-Unicancer and RNPGx networks].
Marie-Anne Loriot, Joseph Ciccolini, Fabienne Thomas, Chantal Barin-Le-Guellec, Bernard Royer, Gérard Milano, Nicolas Picard, Laurent Becquemont, Céline Verstuyft, Céline Narjoz,[...]. Bull Cancer 2018
43
100

Ethical and practical guidelines for reporting genetic research results to study participants: updated guidelines from a National Heart, Lung, and Blood Institute working group.
Richard R Fabsitz, Amy McGuire, Richard R Sharp, Mona Puggal, Laura M Beskow, Leslie G Biesecker, Ebony Bookman, Wylie Burke, Esteban Gonzalez Burchard, George Church,[...]. Circ Cardiovasc Genet 2010
281
100

Engaging Hmong adults in genomic and pharmacogenomic research: Toward reducing health disparities in genomic knowledge using a community-based participatory research approach.
Kathleen A Culhane-Pera, Robert J Straka, MaiKia Moua, Youssef Roman, Pachia Vue, Kang Xiaaj, May Xia Lo, Mai Lor. J Community Genet 2017
15
100

Biobank participants' preferences for disclosure of genetic research results: perspectives from the OurGenes, OurHealth, OurCommunity project.
Nicole L Allen, Elizabeth W Karlson, Susan Malspeis, Bing Lu, Christine E Seidman, Lisa Soleymani Lehmann. Mayo Clin Proc 2014
38
100

Public perceptions of pharmacogenetics.
Steven C Zhang, Carleton Bruce, Michael Hayden, Michael J Rieder. Pediatrics 2014
17
100

An ancillary genomics system to support the return of pharmacogenomic results.
Luke V Rasmussen, Maureen E Smith, Federico Almaraz, Stephen D Persell, Laura J Rasmussen-Torvik, Jennifer A Pacheco, Rex L Chisholm, Carl Christensen, Timothy M Herr, Firas H Wehbe,[...]. J Am Med Inform Assoc 2019
8
100

Cohort Profile: The Right Drug, Right Dose, Right Time: Using Genomic Data to Individualize Treatment Protocol (RIGHT Protocol).
Suzette J Bielinski, Jennifer L St Sauver, Janet E Olson, Nicholas B Larson, John L Black, Steven E Scherer, Matthew E Bernard, Eric Boerwinkle, Bijan J Borah, Pedro J Caraballo,[...]. Int J Epidemiol 2020
16
100

Developing Pharmacogenomic Reports: Insights from Patients and Clinicians.
Laney K Jones, Alanna Kulchak Rahm, Michael R Gionfriddo, Janet L Williams, Audrey L Fan, Rebecca A Pulk, Eric A Wright, Marc S Williams. Clin Transl Sci 2018
12
100

Communicating risk information in genetic counseling: an observational study.
Susan Michie, Kathryn Lester, Julia Pinto, Theresa M Marteau. Health Educ Behav 2005
31
100

Preferences for Return of Genetic Results Among Participants in the Jackson Heart Study and Framingham Heart Study.
Steven Joffe, Deborah E Sellers, Lynette Ekunwe, Donna Antoine-Lavigne, Sarah McGraw, Daniel Levy, Greta Lee Splansky. Circ Genom Precis Med 2019
6
100

Relationship between single nucleotide polymorphisms and haplotypes in DPYD and toxicity and efficacy of capecitabine in advanced colorectal cancer.
Maarten J Deenen, Jolien Tol, Artur M Burylo, Valerie D Doodeman, Anthonius de Boer, Andrew Vincent, Henk-Jan Guchelaar, Paul H M Smits, Jos H Beijnen, Cornelis J A Punt,[...]. Clin Cancer Res 2011
140
100

Patient experiences with pharmacogenetic testing in a primary care setting.
Susanne B Haga, Rachel Mills, Jivan Moaddeb, Nancy Allen Lapointe, Alex Cho, Geoffrey S Ginsburg. Pharmacogenomics 2016
23
100

Revealed identity: a study of the process of genetic counselling.
D Armstrong, S Michie, T Marteau. Soc Sci Med 1998
33
100



Using the framework method for the analysis of qualitative data in multi-disciplinary health research.
Nicola K Gale, Gemma Heath, Elaine Cameron, Sabina Rashid, Sabi Redwood. BMC Med Res Methodol 2013
100

Public perspectives about pharmacogenetic testing and managing ancillary findings.
Susanne B Haga, Genevieve Tindall, Julianne M O'Daniel. Genet Test Mol Biomarkers 2012
40
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.